Literature DB >> 21168175

Emerging issues in public health: a perspective on China's healthcare system.

R E Ling1, F Liu2, X Q Lu2, W Wang3.   

Abstract

China's expenditure on healthcare has increased dramatically over the last 20 years, and three broad trends are seen in the associated health outcomes. First, limited improvements have been achieved to aggregate high-level health outcomes, e.g. infant mortality. Second, development of large and widening health inequalities associated with disparate wealth between provinces and a rural-urban divide. Finally, the burden of disease is shifting from predominantly communicable diseases to chronic diseases. Reasons for the limited gains from investment in healthcare are identified as: (1) increased out-of-pocket expenditure including a high proportion of catastrophic expenditure; (2) a geographical imbalance in healthcare spending, focusing on secondary and tertiary hospital care and greater expenditure on urban centres compared with rural centres; and (3) the commercialization of healthcare without adequate attention to cost control, which has led to escalation of prices and decreased efficiency. Recently, the Chinese Government has initiated widespread reform. Three key policy responses are to establish rural health insurance, partly funded by the Government (the New Rural Co-operative Medical Care System); to develop community health centres; and to aspire to universal basic healthcare coverage by 2020 (Healthy China 2020).
Copyright © 2010 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21168175     DOI: 10.1016/j.puhe.2010.10.009

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  30 in total

1.  Pharmacogenomics in Primary Care: A Crucial Entry Point for Global Personalized Medicine?

Authors:  Gillian Bartlett; Nathalie Zgheib; Aresha Manamperi; Wei Wang; Candan Hizel; Rabia Kahveci; Yasemin Yazan
Journal:  Curr Pharmacogenomics Person Med       Date:  2012

Review 2.  Heart failure in China: a review of the literature.

Authors:  Rinat Ariely; Keith Evans; Tim Mills
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

3.  Hypertension prevalence, awareness, treatment and control among Han and four ethnic minorities (Uygur, Hui, Mongolian and Dai) in China.

Authors:  H Gu; W Li; J Yang; Y Wang; J Bo; L Liu
Journal:  J Hum Hypertens       Date:  2015-01-15       Impact factor: 3.012

4.  Incident hypertension and its prediction model in a prospective northern urban Han Chinese cohort study.

Authors:  Y Chen; C Wang; Y Liu; Z Yuan; W Zhang; X Li; Y Yang; X Sun; F Xue; C Zhang
Journal:  J Hum Hypertens       Date:  2016-06-02       Impact factor: 3.012

Review 5.  Emerging issues in public health: a perspective on Ghana's healthcare expenditure, policies and outcomes.

Authors:  Eric Adua; Kwasi Frimpong; Xia Li; Wei Wang
Journal:  EPMA J       Date:  2017-08-18       Impact factor: 6.543

6.  Prevalence, awareness, treatment and control of high blood pressure among Chinese rural population in Haimen, Jiangsu.

Authors:  T Li; Y Xian; H-M Mao; W-J Jiang; L Zhang; E P F Chow; J-P Huang; Y-H Lu; T Tian; S-Y Jiang; X Zhuang
Journal:  J Hum Hypertens       Date:  2015-10-22       Impact factor: 3.012

7.  Construct validity of the Suboptimal Health Status Questionnaire-25 in a Ghanaian population.

Authors:  Eric Adua; Ebenezer Afrifa-Yamoah; Kwasi Frimpong; Esther Adama; Shantha P Karthigesu; Enoch Odame Anto; Emmanuel Aboagye; Yuxiang Yan; Youxin Wang; Xuerui Tan; Wei Wang
Journal:  Health Qual Life Outcomes       Date:  2021-07-19       Impact factor: 3.186

8.  To see ourselves as others see us.

Authors:  Martin McKee
Journal:  Isr J Health Policy Res       Date:  2012-01-30

9.  Impact on the performance of health workers adopted performance-related contracts in the provision of basic public health service at village and township levels.

Authors:  Yaojun Zhao; Zhen'ang Huo; Jian Wu; Shuangbao Xie; Liang Zhang; Zhanchun Feng
Journal:  Iran J Public Health       Date:  2013-04-01       Impact factor: 1.429

10.  Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China.

Authors:  Bin Wu; Jinfang Shen; Huafeng Cheng
Journal:  BMC Health Serv Res       Date:  2012-11-08       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.